Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209–249 (2021).

Article  PubMed  Google Scholar 

Shuch, B. et al. Understanding pathologic variants of renal cell carcinoma: distilling therapeutic opportunities from biologic complexity. Eur. Urol. 67, 85–97 (2015).

Article  PubMed  Google Scholar 

Marconi, L. et al. Systematic review and meta-analysis of diagnostic accuracy of percutaneous renal tumour biopsy. Eur. Urol. 69, 660–673 (2016).

Article  PubMed  Google Scholar 

Capitanio, U. & Montorsi, F. Renal cancer. Lancet 387, 894–906 (2016).

Article  PubMed  Google Scholar 

Capitanio, U. et al. Epidemiology of renal cell carcinoma. Eur. Urol. 75, 74–84 (2019).

Article  PubMed  Google Scholar 

Rosiello, G., Larcher, A., Montorsi, F. & Capitanio, U. Renal cancer: overdiagnosis and overtreatment. World J. Urol. 39, 2821–2823 (2021).

Article  PubMed  Google Scholar 

Johnson, D. C. et al. Preoperatively misclassified, surgically removed benign renal masses: a systematic review of surgical series and United States population level burden estimate. J. Urol. 193, 30–35 (2015).

Article  PubMed  Google Scholar 

Fernando, A., Fowler, S. & O’Brien, T., British Association of Urological Surgeons. Nephron-sparing surgery across a nation — outcomes from the British Association of Urological Surgeons 2012 national partial nephrectomy audit. BJU Int. 117, 874–882 (2016).

Article  PubMed  Google Scholar 

Richard, P. O. et al. Renal tumor biopsy for small renal masses: a single-center 13-year experience. Eur. Urol. 68, 1007–1013 (2015).

Article  PubMed  Google Scholar 

Amaral, B. S. et al. Renal tumor biopsy: rationale to avoid surgery in small renal masses. Curr. Urol. Rep. 22, 46 (2021).

Article  CAS  PubMed  Google Scholar 

Ljungberg, B. et al. European association of urology guidelines on renal cell carcinoma: the 2022 update. Eur. Urol. 82, 399–410 (2022).

Article  PubMed  Google Scholar 

Ray, S., Cheaib, J. G. & Pierorazio, P. M. Active surveillance for small renal masses. Rev. Urol. 22, 9–16 (2020).

PubMed  PubMed Central  Google Scholar 

Farber, N. J. et al. Renal cell carcinoma: the search for a reliable biomarker. Transl. Cancer Res. 6, 620–632 (2017).

Article  CAS  PubMed  Google Scholar 

Rosellini, M. et al. Prognostic and predictive biomarkers for immunotherapy in advanced renal cell carcinoma. Nat. Rev. Urol. 20, 133–157 (2023).

Article  CAS  PubMed  Google Scholar 

Navani, V. & Heng, D. Y. C. Treatment selection in first-line metastatic renal cell carcinoma-the contemporary treatment paradigm in the age of combination therapy: a review. JAMA Oncol. 8, 292–299 (2022).

Article  PubMed  Google Scholar 

Rosellini, M. et al. Guiding treatment selection with immunotherapy compared to targeted therapy agents in patients with metastatic kidney cancer. Expert. Rev. Precis. Med. Drug. Dev. 7, 131–149 (2022).

Article  Google Scholar 

Jonasch, E. et al. Belzutifan for renal cell carcinoma in von Hippel-Lindau disease. N. Engl. J. Med. 385, 2036–2046 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Powles, T. et al. Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol. 23, 1133–1144 (2022).

Article  CAS  PubMed  Google Scholar 

Linehan, W. M. & Ricketts, C. J. The cancer genome atlas of renal cell carcinoma: findings and clinical implications. Nat. Rev. Urol. 16, 539–552 (2019).

Article  CAS  PubMed  Google Scholar 

Di Meo, A., Bartlett, J., Cheng, Y., Pasic, M. D. & Yousef, G. M. Liquid biopsy: a step forward towards precision medicine in urologic malignancies. Mol. Cancer 16, 80 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Raposo, G. et al. B lymphocytes secrete antigen-presenting vesicles. J. Exp. Med. 183, 1161–1172 (1996).

Article  CAS  PubMed  Google Scholar 

McKiernan, J. M. et al. The detection of renal carcinoma cells in the peripheral blood with an enhanced reverse transcriptase-polymerase chain reaction assay for MN/CA9. Cancer 86, 492–497 (1999).

Article  CAS  PubMed  Google Scholar 

Jahr, S. et al. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res. 61, 1659–1665 (2001).

CAS  PubMed  Google Scholar 

Corro, C. et al. Detecting circulating tumor DNA in renal cancer: an open challenge. Exp. Mol. Pathol. 102, 255–261 (2017).

Article  CAS  PubMed  Google Scholar 

Fleischhacker, M. & Schmidt, B. Circulating nucleic acids (CNAs) and cancer — a survey. Biochim. Biophys. Acta 1775, 181–232 (2007).

CAS  PubMed  Google Scholar 

Gorin, M. A. et al. Circulating tumour cells as biomarkers of prostate, bladder, and kidney cancer. Nat. Rev. Urol. 14, 90–97 (2017).

Article  CAS  PubMed  Google Scholar 

de Groot, A. E., Roy, S., Brown, J. S., Pienta, K. J. & Amend, S. R. Revisiting seed and soil: examining the primary tumor and cancer cell foraging in metastasis. Mol. Cancer Res. 15, 361–370 (2017).

Article  PubMed  PubMed Central  Google Scholar 

van der Toom, E. E., Verdone, J. E., Gorin, M. A. & Pienta, K. J. Technical challenges in the isolation and analysis of circulating tumor cells. Oncotarget 7, 62754–62766 (2016).

Article  PubMed  PubMed Central  Google Scholar 

Gong, J., Maia, M. C., Dizman, N., Govindarajan, A. & Pal, S. K. Metastasis in renal cell carcinoma: biology and implications for therapy. Asian J. Urol. 3, 286–292 (2016).

Article  PubMed  PubMed Central  Google Scholar 

van der Toom, E. E. et al. Prostate-specific markers to identify rare prostate cancer cells in liquid biopsies. Nat. Rev. Urol. 16, 7–22 (2019).

Article  PubMed  PubMed Central  Google Scholar 

Vona, G. et al. Isolation by size of epithelial tumor cells: a new method for the immunomorphological and molecular characterization of circulating tumor cells. Am. J. Pathol. 156, 57–63 (2000).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Reduzzi, C. et al. Development of a protocol for single-cell analysis of circulating tumor cells in patients with solid tumors. Adv. Exp. Med. Biol. 994, 83–103 (2017).

Article  CAS  PubMed  Google Scholar 

Blumke, K. et al. Detection of circulating tumor cells from renal carcinoma patients: experiences of a two-center study. Oncol. Rep. 14, 895–899 (2005).

PubMed  Google Scholar 

Allard, W. J. et al. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin. Cancer Res. 10, 6897–6904 (2004).

Article  PubMed  Google Scholar 

Liu, S. et al. Combined cell surface carbonic anhydrase 9 and CD147 antigens enable high-efficiency capture of circulating tumor cells in clear cell renal cell carcinoma patients. Oncotarget 7, 59877–59891 (2016).

Article  PubMed  PubMed Central  Google Scholar 

Sperger, J. M. et al. Integrated analysis of multiple biomarkers from circulating tumor cells enabled by exclusion-based analyte isolation. Clin. Cancer Res. 23, 746–756 (2017).

Article  PubMed  Google Scholar 

Cristofanilli, M. et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N. Engl. J. Med. 351, 781–791 (2004).

Article  CAS  PubMed  Google Scholar 

Cohen, S. J. et al. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J. Clin. Oncol. 26, 3213–3221 (2008).

Article  PubMed  Google Scholar 

Went, P. et al. Expression of epithelial cell adhesion molecule (EpCam) in renal epithelial tumors. Am. J. Surg. Pathol. 29, 83–88 (2005).

Article  PubMed  Google Scholar 

Zimpfer, A. et al. Prognostic and diagnostic implications of epithelial cell adhesion/activating molecule (EpCAM) expression in renal tumours: a retrospective clinicopathological study of 948 cases using tissue microarrays. BJU Int. 114, 296–302 (2014).

Article  CAS  PubMed